105 related articles for article (PubMed ID: 1405723)
1. No correlation between site of breakpoint in the BCR gene and platelet counts in Philadelphia chromosome-positive CML.
Opalka B; Wandl UB; Kloke O; Beer U; Seeber S; Niederle N
Leuk Res; 1992 Sep; 16(9):937-9. PubMed ID: 1405723
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the clinical relevance of the breakpoint location within M-BCR and the type of chimeric mRNA in chronic myelogenous leukemia.
Rozman C; Urbano-Ispizua A; Cervantes F; Rozman M; Colomer D; Féliz P; Pujades A; Vives Corrons JL
Leukemia; 1995 Jun; 9(6):1104-7. PubMed ID: 7596178
[TBL] [Abstract][Full Text] [Related]
3. Correlation of the site of M-bcr breakpoint with chronic phase duration, blastic crisis lineage and thrombocytosis in Ph1-positive chronic myelogenous leukemia.
Viniou NA; Matzourani M; Yataganas X; Meletis J; Pangalis G; Loukopoulos D
Leuk Lymphoma; 1995 Jul; 18(3-4):335-9. PubMed ID: 8535202
[TBL] [Abstract][Full Text] [Related]
4. Relationship of bcr breakpoint to chronic phase duration, survival, and blast crisis lineage in chronic myelogenous leukemia patients presenting in early chronic phase.
Morris SW; Daniel L; Ahmed CM; Elias A; Lebowitz P
Blood; 1990 May; 75(10):2035-41. PubMed ID: 2337672
[TBL] [Abstract][Full Text] [Related]
5. Further evidence that the site of the breakpoint in the major breakpoint cluster region (M-bcr) may be a prognostic indicator.
Mills KI; Hynds SA; Burnett AK; MacKenzie ED; Birnie GD
Leukemia; 1989 Dec; 3(12):837-40. PubMed ID: 2685475
[TBL] [Abstract][Full Text] [Related]
6. No correlation between locations of bcr breakpoints and clinical states in Ph1-positive CML patients.
Ogawa H; Sugiyama H; Soma T; Masaoka T; Kishimoto S
Leukemia; 1989 Jul; 3(7):492-6. PubMed ID: 2733454
[TBL] [Abstract][Full Text] [Related]
7. Philadelphia chromosome-negative chronic myelogenous leukemia with rearrangement of the breakpoint cluster region. Long-term follow-up results.
Cortes JE; Talpaz M; Beran M; O'Brien SM; Rios MB; Stass S; Kantarjian HM
Cancer; 1995 Jan; 75(2):464-70. PubMed ID: 7812917
[TBL] [Abstract][Full Text] [Related]
8. The relationship between the location of the breakpoint within the M-bcr and clinical parameters.
Mills KI
Leuk Lymphoma; 1993; 11 Suppl 1():73-9. PubMed ID: 8251922
[TBL] [Abstract][Full Text] [Related]
9. The site of the breakpoint within the bcr is a prognostic factor in Philadelphia-positive CML patients.
Mills KI; MacKenzie ED; Birnie GD
Blood; 1988 Oct; 72(4):1237-41. PubMed ID: 3167206
[TBL] [Abstract][Full Text] [Related]
10. The breakpoint cluster region site in patients with Philadelphia chromosome-positive chronic myelogenous leukemia. Clinical, laboratory, and prognostic correlations.
Verschraegen CF; Kantarjian HM; Hirsch-Ginsberg C; Lee MS; O'Brien S; Rios MB; Stass SA; Keating M; Talpaz M
Cancer; 1995 Sep; 76(6):992-7. PubMed ID: 8625225
[TBL] [Abstract][Full Text] [Related]
11. Correlation of M-bcr breakpoint with different chromosomal abnormalities in blast crisis Ph1-positive CML.
Mills KI; Stewart J; Burnett AK
Leuk Res; 1991; 15(11):999-1003. PubMed ID: 1961015
[TBL] [Abstract][Full Text] [Related]
12. Patterns of BCR/ABL gene rearrangements by interphase fluorescence in situ hybridization (FISH) in BCR/ABL+ leukemias: incidence and underlying genetic abnormalities.
Primo D; Tabernero MD; Rasillo A; Sayagués JM; Espinosa AB; Chillón MC; Garcia-Sanz R; Gutierrez N; Giralt M; Hagemeijer A; San Miguel JF; Orfao A
Leukemia; 2003 Jun; 17(6):1124-9. PubMed ID: 12764379
[TBL] [Abstract][Full Text] [Related]
13. Breakpoint zone of bcr in chronic myelogenous leukemia does not correlate with disease phase or prognosis.
Przepiorka D
Cancer Genet Cytogenet; 1988 Nov; 36(1):117-22. PubMed ID: 3203293
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneity of genomic fusion of BCR and ABL in Philadelphia chromosome-positive acute lymphoblastic leukemia.
Rubin CM; Carrino JJ; Dickler MN; Leibowitz D; Smith SD; Westbrook CA
Proc Natl Acad Sci U S A; 1988 Apr; 85(8):2795-9. PubMed ID: 2833755
[TBL] [Abstract][Full Text] [Related]
15. Chronic myelogenous leukemia: molecular diagnostic considerations.
McClure JS; Litz CE
Hum Pathol; 1994 Jun; 25(6):594-7. PubMed ID: 8013950
[TBL] [Abstract][Full Text] [Related]
16. Detection of the breakpoint cluster region-ABL fusion in chronic myeloid leukemia with variant Philadelphia chromosome translocations by in situ hybridization.
Tosi S; Cabot G; Giudici G; Attuati V; Morandi P; Rambaldi A; Döhner H; Biondi A
Cancer Genet Cytogenet; 1996 Jul; 89(2):153-6. PubMed ID: 8697423
[TBL] [Abstract][Full Text] [Related]
17. A novel BCR-ABL transcript e2a2 in a chronic myelogenous leukaemia patient with a duplicated Ph-chromosome and monosomy 7.
Leibundgut EO; Jotterand M; Rigamonti V; Parlier V; Mühlematter D; Tobler A; Solenthaler M
Br J Haematol; 1999 Sep; 106(4):1041-4. PubMed ID: 10520010
[TBL] [Abstract][Full Text] [Related]
18. Different patterns of chromosome and molecular breakage in classic Ph1 chronic myelogenous leukemia (CML) and variant Ph1 CML.
Koduru P; Goh JC; Allen SL; Karp L; Jasti H; DeMarco LC; Lichtman SM
Hematol Pathol; 1991; 5(2):57-66. PubMed ID: 1894583
[TBL] [Abstract][Full Text] [Related]
19. The relationship between the type of bcr-abl hybrid messenger RNA and thrombopoiesis in Philadelphia-positive chronic myelogenous leukemia.
Inokuchi K; Nomura T
Leuk Lymphoma; 1993 May; 10(1-2):9-15. PubMed ID: 8374529
[TBL] [Abstract][Full Text] [Related]
20. New variant Ph translocation in chronic myeloid leukemia: t(Y;22)(p11;q11).
Gallego MS; Baialardo EM; Gutierrez M; Bonduel M; Feliu A
Cancer Genet Cytogenet; 1996 Mar; 87(1):75-8. PubMed ID: 8646747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
